Kobo Biotech Share Price Today | Stock Price & Kobo Biotech Share Screener
As of October 16, 2026, the live Kobo Biotech share price (BSE: KOBO) is ₹4.35, down 1.81% from the previous close, with shares trading between ₹4.35 and ₹4.36 in today's trading session, and a 52-week range of ₹2.09–₹9.82. Check KOBO 52-week chart for the annual price range and momentum. Use the Kobo Biotech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Kobo Biotech opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Kobo Biotech Share Price Chart
Track the current stock price of Kobo Biotech with an interactive chart. Analyse KOBO share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Kobo Biotech stock quote in one place.
The quote of ₹4.35 sits between the 52-week low of ₹2.09 and the 52-week high of ₹9.82, and the latest session moved -1.81% from the previous close.
Kobo Biotech Company Profile - Fundamental Screener
Screen Kobo Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KOBO shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Chemicals sector and the Commodity Chemicals industry, and it trades under ISIN INE881A01015.
Company Details
Classification
Identifiers and Leadership
Kobo Biotech Balance Sheet Screener
Screen KOBO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2015, total assets were ₹396 against total liabilities of ₹396.
Latest statistics put total assets at ₹396 and shareholder funds at ₹53, with a leverage ratio of 3.38.
| Item | 2015 |
|---|---|
Assets |
|
| Total Assets | 396 |
| Current Assets | 290 |
| Fixed Assets | 104 |
Liabilities |
|
| Total Liabilities | 396 |
| Current Liabilities | 79 |
| Non-Current Liabilities | 0 |
Shareholders' Equity |
|
| Total Equity | 53 |
| Share Capital | 23 |
| Reserves & Surplus | 31 |
Kobo Biotech Income Statement Screener - Profit & Revenue Analysis
Screen Kobo Biotech income statement and profit fundamentals. Analyze KOBO quarterly results. Kobo Biotech reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For None-None, revenue was ₹0 and net profit was ₹0.
In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2015-March, shows revenue of ₹103 and net profit of ₹-35.
| Item | None-None | 2015-March |
|---|---|---|
Revenue and Expenses | ||
| Revenue | 0 | 103 |
| Expenses | 0 | 104 |
Operating Costs and Margins | ||
| EBITDA | 0 | -1 |
| Operating Profit % | 0.00% | -1.00% |
| Depreciation | 0 | 10 |
| Interest | 0 | 24 |
Profit and Earnings | ||
| Profit Before Tax | 0 | -34 |
| Tax | 0 | 1 |
| Net Profit | 0 | -35 |
| EPS | 0.00 | -15.47 |
Kobo Biotech Cash Flow Screener - Liquidity Fundamentals
Screen KOBO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2015-March, operating activities generated ₹7, and net cash flow was an outflow of ₹11.
Over the same period, investing activities used ₹5 and financing activities used ₹13.
| Item | 2015-March |
|---|---|
Cash from Operations and Investing | |
| Operating Activities | 7 |
| Investing Activities | -5 |
Financing and Net Cash | |
| Financing Activities | -13 |
| Net Cash Flow | -11 |
Kobo Biotech Shareholding Pattern Screener
See Kobo Biotech shareholding pattern with promoter, FII, and DII holdings. Check Kobo Biotech promoter holding and ownership changes for KOBO on TickJournal, and see how institutional stock price moves affect the market.
In 2024-Mar, promoters held 44.95%, foreign institutions 0.00%, domestic institutions 0.66% and the public 48.27%, spread across 6,767 shareholders.
The shareholder count was 6,767 in 2024-Mar, compared with 6,530 in 2023-Dec.
| Item | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sept | 2022-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% |
Institutional Investors | ||||||||
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.66% | 0.66% | 0.66% | 0.66% | 0.66% | 0.66% | 0.66% | 0.66% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 48.27% | 47.97% | 47.86% | 47.75% | 47.70% | 46.65% | 46.65% | 46.81% |
| Other Holding | 6.12% | 6.42% | 6.53% | 6.64% | 6.69% | 7.74% | 7.74% | 7.57% |
| Shareholder Count | 6,767 | 6,530 | 6,478 | 6,458 | 6,496 | 6,204 | 6,064 | 6,064 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Kobo Biotech. Kobo Biotech dividend yield can be compared with peers and other stocks in the market.
Kobo Biotech Stock Index Membership - Nifty & Sensex
See which indices include Kobo Biotech stock. Check KOBO index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Kobo Biotech Market Events Screener - Corporate Actions
Get Kobo Biotech corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Kobo Biotech stock events that may affect KOBO share price, along with derivatives, futures and options activity and sector gainers.
1 corporate actions are listed, the most recent entry being Change Of Name dated August 17, 2020, with a record date of August 17, 2020.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2020-08-17 | 2020-08-17 | Change Of Name | NA | - |
Kobo Biotech Competitors Screener - Peer Stocks Comparison
Screen KOBO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Tata Chemicals | 19,786 | 48.99 | 15,112 | -3.79% | 354 | 44.06 |
| Deepak Fertilisers & Petrochemicals | 15,808 | 15.77 | 10,355 | 17.69% | 945 | 41.57 |
| Gujarat Narmada Valley Fert & Chem | 7,191 | 11.29 | 8,393 | -0.07% | 586 | 43.68 |
| GHCL | 5,489 | 9.16 | 3,271 | -6.51% | 624 | 42.76 |
| Blue Pearl Agriventures | 5,206 | 8928.00 | 35 | 11666.67% | 1 | 42.60 |
| Chemplast Sanmar | 4,250 | -19.21 | 4,393 | 9.61% | -110 | 38.41 |
| Tanfac Industries | 4,220 | 45.02 | 560 | 45.35% | 88 | 61.61 |
| Gujarat Alkalies & Chemicals | 3,733 | 25277.50 | 4,165 | 6.89% | -65 | 38.56 |
| Thirumalai Chemicals | 2,803 | -18.50 | 2,070 | -1.54% | -46 | 46.26 |
| Fischer Medical Ventures | 2,766 | 139.10 | 112 | 421.86% | 1 | 30.07 |
Kobo Biotech Company Announcements - News & Reports Screener
Screen KOBO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated October 30, 2025.
The next most recent announcements are dated October 30, 2025 and October 30, 2025.
| Date | Update | Actions |
|---|---|---|
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | - |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | - |
Frequently Asked Questions
How is the company valued right now?
The current quote is ₹4.35, within a 52-week range of ₹2.09 to ₹9.82. The P/B ratio is -0.04. Market capitalisation stands at ₹5.61 Cr. The company operates in the Chemicals sector, in the Commodity Chemicals industry, so compare these ratios with its sector peers in the table above.
About This Data
Quotes are sourced from the BSE. Key statistics were last updated on October 19, 2026. This page covers 1 balance sheet periods, 2 income statement periods, 1 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.